651 - 675 of 6230 Results
Title
Year
- Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers2017OPENTitle: Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease CarriersJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 3Start Page: 675End Page: 680Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0161-0Best OA location URL: https://europepmc.org/articles/pmc5878114?pdf=renderCitation Count: 20
- β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway2011OPENTitle: β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling PathwayJournal Name: The Journal of ImmunologyPublisher: Oxford University Press (OUP)Vol: 186Issue #: 7Start Page: 4443End Page: 4454Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.1002449Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/186/7/4443/1340946/1002449.pdfCitation Count: 116
-
OPENTitle: A Role for Neuronal Alpha-Synuclein in Gastrointestinal ImmunityJournal Name: Journal of Innate ImmunityPublisher: S. Karger AGVol: 9Issue #: 5Start Page: 456End Page: 463Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000477990Best OA location URL: https://www.karger.com/Article/Pdf/477990Citation Count: 252
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3302577Citation Count: 130
- Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study2017OPENTitle: Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological StudyJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 4Start Page: 322End Page: 331Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5729910Citation Count: 19
-
OPENTitle: Everyday Action Impairment in Parkinson's Disease DementiaJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 18Issue #: 5Start Page: 787End Page: 798Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s135561771200046xCitation Count: 45
- Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s Disease2017OPENTitle: Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 24Issue #: 3Start Page: 269End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717001011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5820218Citation Count: 19
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 404
-
OPENTitle: A brain network response to sham surgeryJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 8Start Page: 3285End Page: 3288Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci77193Best OA location URL: http://www.jci.org/articles/view/77193/files/pdfCitation Count: 5
-
OPENTitle: Remote control of induced dopaminergic neurons in parkinsonian ratsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 7Start Page: 3215End Page: 3229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci74664Best OA location URL: http://www.jci.org/articles/view/74664/files/pdfCitation Count: 118
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients2014OPENTitle: Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 3Start Page: 1340End Page: 1349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci71640Best OA location URL: http://www.jci.org/articles/view/71640/files/pdfCitation Count: 236
-
OPENTitle: Can Parkinson’s disease be cured by stimulating neurogenesis?Journal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 3Start Page: 978End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci80822Best OA location URL: http://www.jci.org/articles/view/80822/files/pdfCitation Count: 10
- Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients2011OPENTitle: Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 3Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43871Best OA location URL: http://www.jci.org/articles/view/43871/files/pdfCitation Count: 152
- Cerebrospinal fluid–based kinetic biomarkers of axonal transport in monitoring neurodegeneration2012OPENTitle: Cerebrospinal fluid–based kinetic biomarkers of axonal transport in monitoring neurodegenerationJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 122Issue #: 9Start Page: 3159End Page: 3169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci64575Citation Count: 57
-
OPENTitle: Clinical signs in functional (psychogenic) gait disorders: a brief surveyJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0031-1Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/counter/pdf/10.1186/s40734-016-0031-1Citation Count: 23
-
OPENTitle: Cautionary optimism: caffeine and Parkinson’s disease riskJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0037-8Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-016-0037-8Citation Count: 5
-
OPENTitle: Parkinson disease in Gaucher diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0054-2Best OA location URL: http://link.springer.com/content/pdf/10.1186/s40734-017-0054-2.pdfCitation Count: 14
- Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease2009OPENTitle: Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative diseaseJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 515Issue #: 3Start Page: 269End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22040Best OA location URL: http://doi.org/10.1002/cne.22040Citation Count: 54
- Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities2020OPENTitle: Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal AbnormalitiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 5Start Page: 867End Page: 877Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ana.25879Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25879Citation Count: 92
- Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy2013OPENTitle: Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid ImmunotherapyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 3Start Page: e59735End Page: e59735Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0059735Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0059735&type=printableCitation Count: 34
-
OPENTitle: Short- and Long-Term Effects of LRRK2 on Axon and Dendrite GrowthJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61986End Page: e61986Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061986Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061986&type=printableCitation Count: 48
- Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model2013OPENTitle: Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 5Start Page: e65129End Page: e65129Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0065129Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0065129&type=printableCitation Count: 72
- Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain2013OPENTitle: Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the BrainJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61694End Page: e61694Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061694Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061694&type=printableCitation Count: 37
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 117
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5410378Citation Count: 25